Department of Health and Human Services May 29, 2009 – Federal Register Recent Federal Regulation Documents

National Heart, Lung, and Blood Institute; Notice of Closed Meeting
Document Number: E9-12583
Type: Notice
Date: 2009-05-29
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed Meeting
Document Number: E9-12581
Type: Notice
Date: 2009-05-29
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Document Number: E9-12580
Type: Notice
Date: 2009-05-29
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Mental Health; Notice of Closed Meeting
Document Number: E9-12579
Type: Notice
Date: 2009-05-29
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: E9-12578
Type: Notice
Date: 2009-05-29
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Mental Health; Notice of Meeting
Document Number: E9-12569
Type: Notice
Date: 2009-05-29
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Mental Health; Notice of Meeting
Document Number: E9-12568
Type: Notice
Date: 2009-05-29
Agency: Department of Health and Human Services, National Institutes of Health
National Eye Institute; Notice of Meeting
Document Number: E9-12564
Type: Notice
Date: 2009-05-29
Agency: Department of Health and Human Services, National Institutes of Health
Public Meeting of the President's Council on Bioethics
Document Number: E9-12538
Type: Notice
Date: 2009-05-29
Agency: Department of Health and Human Services
The President's Council on Bioethics (Edmund D. Pellegrino, MD, Chairman) will hold its thirty-seventh and final meeting. The full agenda will be posted on the Council's Web site at https:// www.bioethics.gov prior to the meeting. Publications issued by the Council to date include: Human Cloning and Human Dignity: An Ethical Inquiry (July 2002); Beyond Therapy: Biotechnology and the Pursuit of Happiness (October 2003); Being Human: Readings from the President's Council on Bioethics (December 2003); Monitoring Stem Cell Research (January 2004); Reproduction and Responsibility: The Regulation of New Biotechnologies (March 2004); Alternative Sources of Human Pluripotent Stem Cells: A White Paper (May 2005); Taking Care: Ethical Caregiving in Our Aging Society (September 2005); Human Dignity and Bioethics: Essays Commissioned by the President's Council on Bioethics (March 2008); The Changing Moral Focus of Newborn Screening: An Ethical Analysis by The President's Council on Bioethics (December 2008); and Controversies in the Determination of Death: A White Paper by The President's Council on Bioethics (December 2008). Reports are forthcoming on organ transplantation, health care reform, and the future of national bioethics commissions.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: E9-12530
Type: Notice
Date: 2009-05-29
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: E9-12529
Type: Notice
Date: 2009-05-29
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
Beverages: Bottled Water
Document Number: E9-12494
Type: Rule
Date: 2009-05-29
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending its bottled water regulations to require that bottled water manufacturers test source water for total coliform, as is required for finished bottled water products, and to require, if any coliform organisms are detected in source water, that bottled water manufacturers determine whether any of the coliform organisms are Escherichia coli (E. coli), an indicator of fecal contamination. FDA also is amending its bottled water regulations to require, if any coliform organisms are detected in finished bottled water products, that bottled water manufacturers determine whether any of the coliform organisms are E. coli. FDA also is amending the adulteration provision of the bottled water standard to reflect the possibility of adulteration caused by the presence of filth. Bottled water containing E. coli will be considered adulterated, and source water containing E. coli will not be considered to be of a safe, sanitary quality and will be prohibited from use in the production of bottled water. FDA is also amending its bottled water regulations to require that, before a bottler can use source water from a source that has tested positive for E. coli, the bottler must take appropriate measures to rectify or eliminate the cause of E. coli contamination of that source, and that the bottler must keep records of such actions. Existing regulatory provisions require bottled water manufacturers to keep records of new testing required by this rule. This final rule will ensure that FDA's standards for the minimum quality of bottled water, as affected by fecal contamination, will be no less protective of the public health than those set by the Environmental Protection Agency (EPA) for public drinking water.
Agency Information Collection Activities; Proposed Collection; Comment Request; Recordkeeping Requirements for Microbiological Testing and Corrective Measures for Bottled Water
Document Number: E9-12493
Type: Notice
Date: 2009-05-29
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days for public comment in response to the notice. This notice solicits comments on the collection of information provisions of the final rule, ``Beverages: Bottled Water,'' published elsewhere in this issue of the Federal Register, which requires both domestic and foreign bottled water manufacturers that sell bottled water in the United States to maintain records of Escherichia coli testing and corrective measures, in addition to existing recordkeeping requirements.
Agency Information Collection Request. 60-Day Public Comment Request
Document Number: E9-12492
Type: Notice
Date: 2009-05-29
Agency: Department of Health and Human Services
Agency Information Collection Request. 60-Day Public Comment Request
Document Number: E9-12491
Type: Notice
Date: 2009-05-29
Agency: Department of Health and Human Services
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.